NCT06464861View on ClinicalTrials.gov

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Primary Mediastinal B-cell Lymphoma (PMBCL)Mantle Cell Lymphoma (MCL)Diffuse Large B Cell Lymphoma( DLBCL)
Interventions
BIOLOGICAL

CD19-CAR-NK/T

Cord blood derived CD19 CARNK sequential Treatment with 7x19 CAR-T

Trial Locations (1)

310009

RECRUITING

the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER